| Original language | English |
|---|---|
| Journal | Journal of Nuclear Medicine |
| Volume | 62 |
| Issue number | 11 |
| DOIs | |
| State | Published - 1 Nov 2021 |
| Externally published | Yes |
Keywords
- 82 rubidium
- MPI
- Myocardial blood flow
- PET < Modalities
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Journal of Nuclear Medicine, Vol. 62, No. 11, 01.11.2021.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Practical guide for interpreting and reporting cardiac PET measurements of myocardial blood flow
T2 - An information statement from the American Society of Nuclear Cardiology, and the Society of Nuclear Medicine and Molecular Imaging
AU - Bateman, Timothy M.
AU - Heller, Gary V.
AU - Beanlands, Rob
AU - Calnon, Dennis A.
AU - Case, James
AU - deKemp, Rob
AU - DePuey, E. Gordon
AU - Di Carli, Marcelo
AU - Guler, Emel C.
AU - Murthy, Venkatesh L.
AU - Rosenblatt, Jeffrey
AU - Sher, Ronald
AU - Slomka, Piotr
AU - Ruddy, Terrence D.
N1 - Funding Information: deKemp is a consultant for and has received grant funding from Jubilant DraxImage. He receives revenues from Rubidium-82 generator technology licensed to Jubilant DraxImage and from sales of FlowQuant software. Dr. DePuey has no relevant relationships. Dr. Di Carli has received research grant support from Spectrum Dynamics and consulting honoraria from Sanofi and GE Healthcare. Dr. Guler has no relevant relationships. Dr. Murthy receives research support and funding from INVIA Medical Imaging Solutions, research grants and lecture honoraria from Siemens Medical Imaging, an expert witness testimony payment on behalf of Jubilant Draximage, and advisory board payments from Curium and Ionetix. Dr. Murthy has stock in General Electric and Cardinal Health, and stock options in Ionetix. Dr. Rosenblatt has no relevant relationships. Dr. Sher has no relevant relationships. Dr. Slomka participates in software royalties for QPS software at Cedars-Sinai Medical Center. He has received research grant support from Siemens Healthineers. Dr. Ruddy has received research grant support from GE Healthcare and Advanced Accelerator Applications. Funding Information: Dr. Bateman receives research grant support from Bracco, GE Healthcare, and Jubilant DraxImage. He serves as a consultant to AIM, AstraZeneca, Curium, and GE Healthcare. He has an equity interest in Cardiovascular Imaging Technologies. He has intellectual property rights for Imagen PET and SPECT software. Dr. Heller is a Medical Advisor for Molecular Imaging Services and consultant to GE Healthcare. Dr. Beanlands is a Career Investigator supported by the Heart and Stroke Foundation of Canada; the University of Ottawa Heart Institute Vered Chair in Cardiology, and Tier 1 Chair in Cardiovascular Research from the University of Ottawa. He is or has been a consultant for and receives grant funding from GE Healthcare, Lantheus Medical Imaging, Jubilant DraxImage. Dr. Calnon has no relevant relationships. Dr. Case receives research grant support from Bracco, GE Healthcare, and Jubilant DraxImage. He has an equity interest in Cardiovascular Imaging Technologies. He has intellectual property rights for Imagen PET and SPECT software. Dr.
PY - 2021/11/1
Y1 - 2021/11/1
KW - 82 rubidium
KW - MPI
KW - Myocardial blood flow
KW - PET < Modalities
UR - https://www.scopus.com/pages/publications/85119997869
U2 - 10.2967/jnumed.121.261989
DO - 10.2967/jnumed.121.261989
M3 - Article
C2 - 33789935
AN - SCOPUS:85119997869
SN - 0161-5505
VL - 62
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
IS - 11
ER -